Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonacog beta pegol in previously treated children with Haemophilia B
NCT01467427Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- May 2012
- Primary completion
- Nov 2023
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 3 trial of nonacog beta pegol in Hemophilia B (HB), sponsored by Novo Nordisk. Started May 2012; status: completed.
02
Drugs
nonacog beta pegol
03
Conditions
Hemophilia B (HB)
Beyond the preview
Go deeper on NCT01467427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01467427.